Navigation Links
Current Study Offers Window into Automation & Outsourcing Practices Within Top Pharmaceutical Market Research Groups
Date:2/28/2012

s to identify optimal resource levels for maximum competitiveness, regulatory and other changes have continued to erode the effectiveness of the industry's proven business model - a fact pressing executives to reconsider efficient levels of human and capital investment.

This latest study therefore offers an open benchmark opportunity for market research executives throughout the bio-pharma and medical device sectors.

To view or participate in the online survey, follow this link: http://www.surveygizmo.com/s3/800600/Market-Research-Efficiency.

For assistance or questions related to this study, contact research team leader Vahid Sanii at vsanii@best-in-class.com or (919) 767-9254. Responses are requested by Mar. 9, 2012.

There is no cost to participate, and all benchmark participants will receive the complete, blinded research results and analysis for free. This study will generate comparative metrics and executive insights that participants can use in the future to help assess what outsourcing levels and automation processes are right for different sizes of company.

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Medical Alarm Concepts Investor Update -- News on Current Initiatives
2. Updated Survival Data from Study Comparing TTF™ (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology
3. Current Trends and Future Directions in Physician E-Sampling Programs for the Pharmaceutical Industry
4. Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling
5. S1P1 Agonists are Currently Indicated For Treatment of Multiple Sclerosis
6. Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates
7. ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price
8. MedInformatix Practice Management and Electronic Medical Records Simplifies Texas Dermatology Practices Current and Future Operations
9. Groupe Athena, Inc. Provides Guidance on Current Orders
10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
11. Assured Pharmacy Upgrades to OTC Pink Current Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014  ResMed (NYSE: RMD ) ... Exchange program, a comprehensive suite of software and ... other health care providers. ResMed ... patient information. It integrates valuable sleep and respiratory ... management platforms with customers, in-house or third-party electronic ...
(Date:10/20/2014)... , Oct. 20, 2014   Taiho Oncology, ... Ltd. ( Japan ), announced that ... Fast Track designation for TAS-102 (nonproprietary names: trifluridine ... under investigation for the treatment of refractory metastatic ... initiated a rolling NDA submission to the FDA. ...
(Date:10/20/2014)... LONDON , October 20, 2014 ... study of its novel, low volume bowel preparation, NER1006, ... of the American College of Gastroenterology (ACG), ... end point of stool weight and co-primary endpoint of ... efficacy with NER1006 vs. MOVIPREP ® in screening ...
Breaking Medicine Technology:ResMed Launches ResMed Data Exchange 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2
... 7 MO BIO Laboratories, Inc., the ... announces the launch of a groundbreaking new product, LifeGuard ... samples upon collection. LifeGuard solution will enable researchers ... degradation or changes in transcript levels during transport to ...
... RIDGE, N.J., Oct. 7 With the growth in the ... WIRELESS I.T. & Entertainment 2009® that it is offering OnCare ... Manager application that helps address the specific needs of mobile ... efficient. , Designed specifically for use by home ...
Cached Medicine Technology:MO BIO Laboratories, Inc. Launches LifeGuard(TM) Soil Preservation Solution 2Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive 2
(Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Voicheck as Assistant Director of their CentralSource ... in managing the innovative turnkey drug sourcing, distribution, ... Matthew brings over 12 years of industry experience, ... Myoderm at the peak of their international success ...
(Date:10/20/2014)... Final Cut Pro X Plugin developers from ... theme for FCPX filmmakers . , “Fun, cool, and ... Citrus theme” Says Christina Austin, CEO of Pixel Film Studios. ... , Citrus comes with all the tools needed for a ... transitions for added style, a title screen for an introduction, ...
(Date:10/20/2014)... October 20, 2014 Do you ever ... Here comes a wonderful app Metassessor for teachers, specialists ... company helped its client “Intervention Development LLC” to ... app is designed for iOS 4.3 or later and ... app is optimized for iPhone 5. It is now ...
(Date:10/19/2014)... Dallas, Texas (PRWEB) October 20, 2014 ... therapeutic development for Partial Seizure, complete with comparative ... target, mechanism of action (MoA), route of administration ... and featured news and press releases. It also ... for Partial Seizure and special features on late-stage ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4
... Ramadoss has added a new twist to the cola row ... added pesticides.// , ,"All carbonated drinks like Pepsi and ... a comprehensive policy on such drinks are needed," he said ... of Madras Medical College. ,Ramadoss added that the issue ...
... and Prevention say that mothers who are at a low-risk ... deliver their baby by C-section// rather than vaginally. The report ... Perinatal Care. For the study researchers looked at 5.7 million ... ,In general, neonatal ( ,The overall rate ...
... Boston have discovered a new common, noncoding variant in ... with age-related macular degeneration// (AMD), the leading cause ... 60 and older. Their analyses, for the first time, ... to estimate individual risk of advanced AMD. They observed ...
... people and the possible link between these changes and the ... Forest University School of Medicine// . ,Comparison of ... disorder with the tissue from normal people will be done ... from the National Institute of Mental Health. ,The ...
... Institutet in Sweden and Makerere University in Uganda finds that ... and this is the reason for pregnant women and children ... worst of the four malaria parasites that infect man. It ... of pregnant women, with fatal consequences for both her and ...
... claim to have discovered how a specific chemotherapy drug helps ... was conducted on the use of a virus in animals ... led by scientists from the Ohio State University Comprehensive Cancer ... Research Institute, and has been published in the August 22nd ...
Cached Medicine News:Health News:Cesarean Section May Increase Infant Mortality Rates in Low-Risk Women 2Health News:AMD influenced by Variation in 3 Genes 2Health News:AMD influenced by Variation in 3 Genes 3Health News:Brain changes in schizophrenia to be analyzed 2Health News:Brain changes in schizophrenia to be analyzed 3Health News:Malarial Parasite Hides In Placenta 2Health News:Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively 2Health News:Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively 3
Lyphochek Coagulation Control is a human plasma control for monitoring the performance of routine coagulation tests. It has an extended reconstituted stability which helps reduce waste and save money...
Lyphochek® Hemoglobin A1C Linearity Set is a human whole blood based product designed to verify linearity throughout the patient reportable range of hemoglobin A1C assays....
... Hematology-16 Control is specifically ... most hematology analyzers that ... parameters and 3-part white ... trilevel control can be ...
Each Liquichek Seroconversion Panel features a series of serum specimens drawn over time from one individual to show the progression from a negative to a positive disease state....
Medicine Products: